ArriVent BioPharma, Inc. (AVBP) stock
AVBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.01−0.06 (-0.46%)
Close on Nov 13, 2026Market cap $641.49MP/E –Yield –
ArriVent BioPharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ArriVent BioPharma's enterprise value was $279.44M on Nov 11, 2026, against $636.89M a year earlier. Over the last 3 years it ranged from -$105.03M to $1.25B, with a median of $565.00M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $279.44M | -46.4% |
| 2025 | Dec 31, 2025 | $521.68M | -15.1% |
| 2024 | Dec 31, 2024 | $614.76M | – |
See a number that looks wrong?